Bybit CEO Ben Zhou Strengthens Indonesia Focus at Coinfest Asia 2025 and Co-Hosts Strategic Event with Tether to Explore the Future of Crypto in Southeast Asia
DUBAI, UAE, Sept. 3, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Axis Bank Launches Sparsh Week 2025: ‘Raising the Bar’ Nationwide
MUMBAI, India, Sept. 3, 2025 /PRNewswire/ -- Axis Bank, one of the largest…
VLCC Unveils The Great Indian Beauty Festival 2025 – India’s Biggest Beauty Celebration of the Year
Month-long festival introduces science-led global skincare breakthroughs with offers up to 50%…
Landmark Group announces the appointment of Jayanti Ganguly as CEO of Home Centre, India
BENGALURU, India, Sept. 3, 2025 /PRNewswire/ -- Home Centre, India's most preferred destination…
TBO TO ACQUIRE CLASSIC VACATIONS FROM THE NAJAFI COMPANIES TO EXPAND ITS GLOBAL REACH INTO NORTH AMERICA
TBO's purchase of the leading U.S. luxury travel wholesaler elevates its premium…
CGTN: What to choose between war and peace? China’s V-Day message to the world is loud and clear
BEIJING, Sept. 3, 2025 /PRNewswire/ -- China held a commemoration on September…
Chunghwa Telecom Earns Frost & Sullivan’s 2025 Taiwan Technology Innovation Leadership Recognition in the 5G Industry
Leading through cutting-edge 5G innovation and cross-industry applications, Chunghwa Telecom showcases market-defining advances…
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI IQLIK(lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease Under Fast Track Status
LEQEMBI IQLIK, if approved for initiation dosing, would be the first and…
Cycurion to Present at the H.C. Wainwright 27th Annual Global Investment Conference
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU)…
adidas Reimagines Equipment for the Course Focused on the Essentials and Nothing More
Limited capsule features assortment of apparel and accessories inspired by iconic designs…
